Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial.
Authors: Rao MKP; General Medicine, Rajiv Gandhi Institute of Medical Sciences, Srikakulam, IND., Siddananjappa L; Dermatology, Glow Skin Centre, Nagpur, IND., Sidana N; Dermatology, Apex Hospitals Pvt. Ltd., Jaipur, IND., Deshmukh A; Dermatology, Mahatma Gandhi Mission Medical College, Aurangabad, IND., Diwari B; Skin and Venereal Diseases, Hi-Tech Medical College and Hospital, Bhubaneswar, IND., Podder I; Dermatology and Veneriology, College of Medicine and Sagore Dutta Hospital, Kolkata, IND., Kumar S; Skin, Venereal Diseases and Leprosy, Sawai Man Singh (SMS) Medical College and Hospital, Jaipur, IND., Mittal R; New Product Development, Zydus Healthcare Ltd., Ahmedabad, IND., Daultani P; New Product Development, Zydus Healthcare Ltd., Ahmedabad, IND., Jaiswal A; Medical Affairs, Zydus Lifesciences, Mumbai, IND., Chinda M; Dermatology, Zydus Lifesciences, Mumbai, IND.
Source: Cureus [Cureus] 2024 May 12; Vol. 16 (5), pp. e60162. Date of Electronic Publication: 2024 May 12 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.60162